Form 8-K - Current report:
SEC Accession No. 0001628908-25-000098
Filing Date
2025-06-20
Accepted
2025-06-20 06:32:06
Documents
14
Period of Report
2025-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evh-20250619.htm   iXBRL 8-K 39265
2 EX-99.1 a20250620exhibit991.htm EX-99.1 11912
6 image_0a.jpg GRAPHIC 96105
  Complete submission text file 0001628908-25-000098.txt   311211

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20250619.xsd EX-101.SCH 1797
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20250619_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20250619_pre.xml EX-101.PRE 13057
17 EXTRACTED XBRL INSTANCE DOCUMENT evh-20250619_htm.xml XML 2943
Mailing Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209
Business Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 251059012
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)